Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)

China flag China · Delayed Price · Currency is CNY
2.250
-0.050 (-2.17%)
May 20, 2026, 11:29 AM CST
Market Cap7.32B -7.5%
Revenue (ttm)1.58B -13.1%
Net Income-408.05M
EPS-0.13
Shares Out3.18B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume20,120,984
Average Volume36,429,875
Open2.290
Previous Close2.300
Day's Range2.240 - 2.300
52-Week Range2.190 - 3.230
Beta0.15
RSI33.35
Earnings DateApr 30, 2026

About SHA:600252

Guangxi Wuzhou Zhongheng Group Co., Ltd, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceuticals in China. The company offers traditional Chinese medicine, including Xueshuantong injection, Zhonghua Dieda Wan for traumatic injuries, Fuyanjing capsules, JieShiTong tablets, snake gall and fritillaria liquid, Kunyuean granules, and compound clam oral liquid for cardiovascular and cerebrovascular, neurology, endocrinology, orthopedics, ophthalmology, gynecology, pediatrics, respiratory, urinary system, and othe... [Read more]

Sector Healthcare
Founded 1993
Employees 2,843
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600252
Full Company Profile

Financial Performance

In 2025, SHA:600252's revenue was 1.75 billion, a decrease of -16.92% compared to the previous year's 2.10 billion. Losses were -357.09 million, -5.28% less than in 2024.

Financial Statements